The smooth muscle myosin heavy chains (SMHC) are motor proteins powering smooth muscle contraction [1] [2] [3] [4] . Alternate splicing of SHMC gene at the C-terminus produces SM1, and SM2 myosin isoforms; SM2 (200 kDa) contains a unique 9-aminoacid sequence at the carboxyl terminus, whereas SM1 (204 kDa) has a 43 amino acid non-helical tail region [5] [6] [7] . To date the functional difference between C-terminal isoforms has not been established; therefore, we used an exon-specific gene targeting strategy and -/-mice died within 30 days after birth.
The peri-mortal SM2 -/-mice showed reduced body weight, distention of the bladder and alimentary tract, and end-stage hydronephrosis. Interestingly, strips from SM2 -/-bladders showed increased contraction to K + depolarization or M3 receptor activation. These results suggest that SM2 myosin has a distinct functional role in smooth muscle, and the deficiency of SM2 increases smooth muscle contractility, and causes dysfunctions of smooth muscle organs, including the bladder that leads to the end-stage hydronephrosis and postnatal death.
We and others have previously shown that alternate splicing of the SMHC gene at the N-and C-terminus produces four isoforms (SMA/B, SM1/2) that are restricted to the smooth muscle lineage [5] [6] [7] [8] . During embryonic development in mice, SM1 appears early by 10.5 days post-coitum, whereas SM2 appears late in fetal development around birth and increases steadily during the postnatal stages; reaching a SM1 to SM2 ratio of 1:1 in adult stages 9 . The ratio of SM2:SM1 is both tissue-and species-specific, and is altered during disease states; decreased expression of SM2 has been found in primary pulmonary hypertension, in neointimal smooth cells of injured or/and atherosclerotic vessels, and in obstructive bladder disease [10] [11] [12] [13] [14] . Studies also suggest that an alteration in SM2 : SM1 ratio could modify force development [15] [16] [17] [18] . In the present study, we used an exon-specific gene-targeting strategy to generate a mouse model that is deficient in SM2 but continues to express SM1. To ablate SM2 , exon-41 encoding nine c-terminal amino acids, a stop signal, along with its flanking 5'and 3' splicing sequences was replaced with a neomycinresistance cassette under the HSV-TK promoter in the reverse orientation in a targeting vector ( Fig.1 A) . Successful targeting and germ-line transmission was confirmed by longdistance PCR analyses using primers specific for the wild-type (WT), and mutant alleles (data not shown). Both heterozygous (SM2 +/-) and homozygous (SM2 -/-) pups were delivered in an expected Mendelian ratio, which suggests that loss of SM2 does not result in embryonic lethality.
The homozygous newborns had normal body size at birth; however by day 20, the SM2 -/-mice showed a significant decrease in body weight compared to the SM2 +/+ mice (8.88 ± 0.35 g vs. 15 .61 ± 1.2 g; P < 0.001) and about ~ 50% of the homozygous mice died during the first two weeks. Mice that survived beyond two weeks showed enlargement of the gastrointestinal system, distention of the bladder, enlarged kidneys (due to development of hydronephrosis) and retention of urine in the bladder (Fig 1B) .
All homozygous SM2 -/-mice died within 4 weeks after birth but the heterozygous mice appeared normal and were able to breed. The peri-mortal SM2 -/-mice showed severe urinary retention in the renal pelvis and bladder body, and developed end-stage hydronephrosis. We also found that the bladder body of peri-mortal SM2 -/-mice was significantly enlarged, but its wall thickness was reduced (Fig 1B and C) . On the other hand, the morphology of the cardiovascular system including aorta and the heart was not affected in SM2 -/-mice (data not shown). These results indicate that SM2 is essential for the in vivo function of the bladder and alimentary tract.
To understand the molecular bases for the observed phenotype, we determined if protein expression was altered by deletion of the SM2-specific exon. Samples from neonate bladders from mice 4-7 days of age, a stage where the SM2 -/-bladder was not distended, were examined. Quantitative Western blot analysis showed that SM2 protein was absent in SM2 -/-bladder as expected and in the SM2 +/-bladder, its expression level was decreased by 20% (Fig 2A) . Also, there was a decrease in the level of SM1 in SM2
+/-and SM2 -/-bladder (27% and 56%, respectively; Fig 2A) . On the other hand, the levels of -SM-actin and tropomyosin were not altered. Total SMHC protein as assessed by
Coomassie-blue staining of the gel was decreased by 16% and 62% in SM2 +/-, and SM2
-/-bladder, respectively (Fig 2A) . However, the SMHC protein band density in aorta was very similar between SM2 -/-and SM2 +/+ mice (Fig 2A) , which suggests that the decrease in SM1 level in SM2 +/-and SM2 -/-bladders represents an adaptive response to the loss of SM2. Furthermore, electron microscopic examination of the bladder sections showed that the overall morphology and structure of smooth muscle cells were similar between null and SM2 +/+ mice. These results suggest that deletion of the SM2 exon selectively alters thick filament proteins, and does not affect the overall smooth muscle cell structure in mouse bladder. in peak and sustained force, respectively; P<0.001) compared to that of SM +/+ , (Fig 2A) .
These results altogether suggest that the complete loss of SM2 myosin increases smooth muscle contractility, whereas a partial loss of SM2 could be compensated in the presence of a concomitant decrease in SM1.
To further explore the mechanisms responsible for increased contractility in SM2 The above results suggest that SM2 myosin function distinctly from the other SHMC isoform, i.e. SM1, and an appropriate ratio of SM1and SM2 myosin is essential for the normal contractility of smooth muscle in organs, such as the bladder. In support of this idea, the ablation of SMHC gene, ( total loss of SMHC protein ) resulted in a drastic decrease of smooth muscle contraction 20 . In addition, the loss of SM2 in SM +/-or SM -/-bladders was accompanied by a concomitant decrease of SM1. SM +/-bladder (despite a decrease in SM2) developed comparable force to that of SM +/+ mice. This further underscores a unique role for SM2, and suggests that in smooth muscle there exists a mechanism to maintain a constant ratio of SM1 and SM2. A recent study also showed that the SM1 and SM2 ratio was not changed by transgenic over-expression of either SM1 or SM2; while the transgenic protein was expressed, it was offset by a decrease in the levels of endogenous SM1 or SM2 proteins in the mouse bladder 18 .
Also of note is that in the presence of increased smooth muscle contractility, SM2 -/-mice showed urinary retention in bladder or/and the renal pelvis. This might reflect an increased urinary flow resistance, as observed in obstructive diseases. SM2 has been found to be unevenly distributed among smooth muscle tissues. For example, in the urethra, SM2 is more abundant than in the bladder 21 . Thus, it remains to be further understood how the ablation of SM2 affects muscle function in the ureter and urethra or the functional coordination between organs involved in the in vivo regulation of urinary emptying.
In summary, in this study we generated a mouse model specifically deficient in SM2. Our results suggest that SM2 myosin has a distinct function and is necessary for overall smooth muscle contractility. Furthermore ablation of SM2 results in hypercontractility of smooth muscle but causes dysfunction of smooth muscle organs, including the bladder that leads to development of end-stage hydronephrosis and postnatal death.
Methods

Generation of SM2-deficient mice
Genomic 
Tissue preparation
Neonate mice (4-7 days) were used for the experiments. Bladders were isolated and cut open, and the mucosa was removed by dissection under a binocular microscope.
For the functional analyses, muscles from the front wall were cut transversally into 1 mm wide and 2 mm long strips. The strips were tied with thread filaments to form a loop at both ends separated by a distance of 1 mm. In some experiments the thoracic aortas were also isolated and dissected free of adherent tissues for protein analyses.
Analyses of protein expression
Protein expression was analyzed with western blot as described elsewhere 22 .
Briefly, crude myofibril proteins isolated from bladder muscle were separated by electrophoresis on SDS-PAGE (5% for SM2 and SM1; 10% for -actin and tropomyosin; 15% for MLC20), and transferred to a nitrocellulose membrane. Proteins were sequentially probed with respective first and secondary antibodies. Anti-SM1 and Anti-SM2 antibodies were kindly provided by Dr. AF Martin and Dr. R Nagai, respectively.
Anti--actin and anti-MLC20 antibodies were purchased from Sigma (St Louis, MO). In some experiments, the SDS-PAGE (10%) gels were stained with Coomassie-blue to directly visualize both SMHC and actin. Band densities were quantified and analyzed with a Biochemi System (UVP, Upland, CA).
Electron Microscopic examination
The bladders were expanded in situ and fixed with 4% glutaraldehyde in 0.1M phosphate buffer (PH7. 
Analysis of intact bladder smooth muscle function
Muscle strips were attached with the loops to two tungsten wires in an organ bath (3 ml) filled with physiological salt solution 23 (PSS) maintained at 37 o C. One wire was fixed, and the other was connected to a force transducer (AE801, Holten, Norway).
Tissues were set at 1.5 times resting length (at which length the contractile response to 60 mM K + was maximal and reproducible), and the contractions to the subsequent 10-50 mM K + or Carbachol (1 M) were determined sequentially. Force was expressed as a percentage of peak value evoked by 60 mM K + .
Myofilament Ca 2+ sensitivity
Muscle strips were attached to the force apparatus as described above, and set at 
Measurement of MLC20 phosphorylation
Muscle strips (1 x 2 mm 2 ) were placed in 37 o C PSS or 40 mM K + for 5 min and the reactions were stopped with 90% acetone, 10% trichloroacetic acid and 10 mM dithiothreitol (DTT) chilled at -80 o C. Proteins were extracted, separated on Urea/glycerol gel (with the amount adjusted to achieve similar total MLC20 content between SM2
+/+ and SM2 -/-mice), and transferred onto a nitrocellulose membrane as described previously 24 . Phosphorylated and un-phosphorylated MLC20 were probed with anti-MLC20 antibody, as in western blot analyses.
Statistics
For statistical evaluation, values were presented as mean ± SE. Comparison of two means was performed by unpaired Student's t test. Where more than two means were compared, 1-way or 2-way ANOVA followed by Dunnett's or Bonferroni's post hoc test was used. P <0.05 was considered to be statistically significant. 
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